Skip to Content
Weed and Booze v1
Today’s Change

A symphony is an automated trading strategy — Learn more about symphonies here

About

Daily rotation between cannabis and alcohol. If biotech is beating staples, hold a 2x cannabis fund plus the 3 strongest cannabis‑related names; otherwise hold the 3 strongest beer/spirits stocks. Simple momentum signal, concentrated, and high turnover.
NutHow it works
Each day it checks: if a biotech fund (XBI) has been stronger lately than a consumer‑staples fund (XLP), it buys “weed”; otherwise it buys “booze.” Weed = equal weights in 4 slots: a 2x cannabis fund (MSOX) plus the 3 strongest names from a cannabis/related list. Booze = equal weights in the 3 strongest beer/spirits stocks. “Strongest” means best ~2‑week average returns.
CheckmarkValue prop
A regime-driven cannabis/alcohol momentum strategy aims to capture alpha in regime shifts, diversifying S&P exposure. Out-of-sample results show higher risk and larger drawdowns, suitable only for experienced, risk-tolerant investors.
1M
3M
6M
YTD
1Y
3Y
Max
Performance
Compared to selected benchmarks
Alpha
Beta
R2
R
0.09
0.73
0.02
0.14
Performance Metrics
Cumulative Return
Annualized Return
Trailing 1M Return
Trailing 3M Return
Sharpe Ratio
66.95%
17.22%
-1.67%
2.89%
1.03
-35.33%
-12.64%
-45.41%
-46.66%
0.24
Initial Investment
$10,000.00
Final Value
$6,467.23
Regulatory Fees
$139.42
Total Slippage
$656.98
Invest in this strategy
OOS Start Date
May 1, 2024
Trading Setting
Daily
Type
Stocks
Category
Momentum, sector rotation, cannabis, alcohol, consumer staples, biotech, leveraged etf, daily rebalance, long-only
Tickers in this symphonyThis symphony trades 0 assets in total
Ticker
Type